According to the latest research, the skin-related beauty market in China is estimated to increase at the rate of 10.1% each year in the period from 2023 to 2029. Skin-related beauty refers to the products and treatments aimed at improving the health, appearance, and overall condition of the skin. It…
China Skin Care and Treatment Market 2023
The maintenance of skin health and prevention of skin conditions through proper skincare practices are crucial. Skincare not only shields the skin from environmental factors like UV radiation, pollution, and harsh weather conditions but also assists in managing and alleviating various skin conditions such as dryness, acne, and dermatitis. Moreover, skincare plays a vital role in wound healing, radiation therapy, and minimizing the side effects of certain medications.
According to the latest research, the skin care and treatment market in China is projected to experience significant growth. It is anticipated to increase by USD 79.0 billion during the period of 2023-2029, with a compound annual growth rate (CAGR) of 9.88%. Several factors contribute to this growth, including the rising consumer awareness about skincare, increasing disposable income, and evolving lifestyles. Consumers are becoming more conscious of their skin health and are willing to invest in high-quality skincare products, which drives the demand for such products and propels the growth of the market.
This industry report provides comprehensive market estimates for the Chinese market, coupled with a detailed analysis of its types and regions. The skin care and treatment market in China can be segmented based on type into functional skincare, medical dressing, and general skincare. Among these segments, the general skincare segment accounted for the highest revenue generation in 2022. In terms of geographic segmentation, the market is further divided into North China, Northeast China, East China, South Central China, Southwest China, and Northwest China.
The functional skincare market can be further classified into recombinant collagen, animal-derived collagen, hyaluronic acid, active ingredients from plants, and others. Among these subsegments, the active ingredients from plants held the largest market share in 2022. However, the recombinant collagen segment is expected to exhibit the highest CAGR during the forecast period. Additionally, the medical dressing market has been categorized into recombinant collagen, animal-derived collagen, hyaluronic acid, and others. Among these categories, the recombinant collagen segment is projected to grow at the highest CAGR during the forecast period.
Major Companies and Competitive Landscape
The skin care and treatment market in China is highly competitive, with several key players dominating the industry. These leading companies include Yunnan Botanee Bio-technology Group Co. Ltd., L’Oréal S.A., Bloomage Biotechnology Corp. Ltd., Kao Corporation, Harbin Fuerjia Technology Co. Ltd., Allmed Medical Products Co. Ltd., Guangzhou Trauer Biotechnology Co. Ltd., and Winner Medical Co. Ltd.
This data-centric report emphasizes market trends, status, and outlook for each segment. With a comprehensive assessment across major geographies, this report serves as a valuable asset for existing market players, new entrants, and future investors.
Why buy this report?
Get a detailed picture of the China Skin Care and Treatment Market
Identify segments/areas to invest in over the forecast period in the China Skin Care and Treatment Market
Understand the competitive environment, the market’s leading players
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
China Skin Care and Treatment Market 2023 - Report Scope
|Market Size (2022)|
USD 95.4 Billion
North China, Northeast China, East China, South Central China, Southwest China, Northwest China
Yunnan Botanee Bio-technology Group Co. Ltd., L'Oréal S.A., Bloomage Biotechnology Corp. Ltd., Kao Corporation, Harbin Fuerjia Technology Co. Ltd., Allmed Medical Products Co. Ltd., Guangzhou Trauer Biotechnology Co. Ltd., Winner Medical Co. Ltd.